SMARCA2 and esophageal squamous cell carcinoma: Given the shared p53 loss across all lesions and the progressive attenuation and loss of BRM/SMARCA2 expression, it was concluded that the hepatic tumor originated from an esophageal SCC and underwent a sarcomatoid transformation at the metastatic site.